Human insulin as safe and effective to treat type 2 diabetes as costlier insulin analogs


(Yale University) Patients with Type 2 diabetes who were treated with the newer generation of insulin analog drugs did not have substantially better outcomes than those treated with less costly human insulin, according to a study by Yale School of Medicine researchers and colleagues at Kaiser Permanente. The study is published in the June 23 issue of Journal of the American Medical Association.

Leave A Reply

Your email address will not be published.